by Walter Gunzburg | Dec 21, 2022 | News
Austrianova/SGAustria is pleased to announce that during the last year it has made major progress and achieved some significant milestones. During 2022, as well as our ongoing projects, the Company has acquired three new partners all involved in cutting edge therapy...
by Walter Gunzburg | Nov 29, 2022 | News
‘ ”’ ‘ All therapeutics go through three phasese of clinical trial testing (phase 1, 2 and 3) before market authorization is possible and they are approved for use in patients. Because late stage clinical trials involve more subjects than early...
by Walter Gunzburg | Sep 16, 2022 | News
Austrianova Chief Production Officer speaking at Bio Asia Pacific 2022 about Austrianova’s GMP Cell Encapsulation and Cell Banking...
by Walter Gunzburg | Jun 30, 2022 | News
WARNING: it has come to our attention that persons unknown are impersonating Austrianova through job interviews and job offers via Austrianova.co (not our official address which is Austrianova.com). We are currently not hiring and we do NOT conduct any...
by Walter Gunzburg | Apr 23, 2022 | Press Release
SINGAPORE, April 21st, 2022Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased to announce that it has been awarded ISO 9001:2015 certification for the production of encapsulated and non-encapsulated cells at its facility in...
by Walter Gunzburg | Jul 12, 2021 | News
SINGAPORE, July 12th, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is delighted to announce the appointment of Pierre Faddoul to the Austrianova management team as the company’s new Chief Financial Officer (CFO)....
by Walter Gunzburg | Jul 7, 2021 | Press Release
SINGAPORE, July 7th, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased and honoured to announce that, after extensive due diligence, Real Tech Fund (managed by Real Tech Holdings, Japan) has invested an undisclosed...
by Walter Gunzburg | Apr 22, 2021 | Press Release
Singapore based Company envisages going public via SPAC merger or traditional IPO SINGAPORE, April 22, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased to announce that it has signed an Agreement with GEM Global...
by Walter Gunzburg | Nov 30, 2020 | Press Release
Austrianova announced today that a key publication on the ability of its patented technology, Bac-in-a-Box, to completely protect probiotics from acidic conditions found in the stomach has been published in the well respected journal “Microbial Cell Factories”...
by Walter Gunzburg | Jul 28, 2020 | Press Release
S.E. Asian company, Austrianova, headquartered in Singapore, announced today that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA). This DMF provides all confidential and detailed information covering the production of...
